These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32595513)

  • 1. New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection.
    Yan S; Sun H; Bu X; Wan G
    Front Pharmacol; 2020; 11():912. PubMed ID: 32595513
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
    Dakal TC
    Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the integrin binding motifs within SARS CoV-2 spike protein and MHC class II alleles playing the key role in COVID-19?
    Gerencer M; McGuffin LJ
    Front Immunol; 2023; 14():1177691. PubMed ID: 37492575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an α
    Bugatti A; Filippini F; Bardelli M; Zani A; Chiodelli P; Messali S; Caruso A; Caccuri F
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Cross-Talk between Integrins and Cadherins Leads to a Loss of Vascular Barrier Integrity during SARS-CoV-2 Infection.
    Nader D; Kerrigan SW
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Spike Protein Unlikely to Bind to Integrins
    Othman H; Messaoud HB; Khamessi O; Ben-Mabrouk H; Ghedira K; Bharuthram A; Treurnicht F; Achilonu I; Sayed Y; Srairi-Abid N
    Front Mol Biosci; 2022; 9():834857. PubMed ID: 35237662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein.
    Makowski L; Olson-Sidford W; W-Weisel J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.
    Beaudoin CA; Petsolari E; Hamaia SW; Hala S; Alofi FS; Pandurangan AP; Blundell TL; Chaitanya Vedithi S; Huang CL; Jackson AP
    Biochem Biophys Res Commun; 2023 Jul; 666():61-67. PubMed ID: 37178506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet αIIbβ3 integrin binds to SARS-CoV-2 spike protein of alpha strain but not wild type and omicron strains.
    Ito K; Goto K; Shirakawa R; Horiuchi H; Ogasawara K
    Biochem Biophys Res Commun; 2023 May; 657():80-85. PubMed ID: 36996544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling.
    Robles JP; Zamora M; Adan-Castro E; Siqueiros-Marquez L; Martinez de la Escalera G; Clapp C
    J Biol Chem; 2022 Mar; 298(3):101695. PubMed ID: 35143839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19.
    Nader D; Fletcher N; Curley GF; Kerrigan SW
    PLoS One; 2021; 16(6):e0253347. PubMed ID: 34161337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin activation is an essential component of SARS-CoV-2 infection.
    Simons P; Rinaldi DA; Bondu V; Kell AM; Bradfute S; Lidke D; Buranda T
    bioRxiv; 2021 Jul; ():. PubMed ID: 34312625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells.
    Bugatti A; Filippini F; Messali S; Giovanetti M; Ravelli C; Zani A; Ciccozzi M; Caruso A; Caccuri F
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 RBD and Its Variants Can Induce Platelet Activation and Clearance: Implications for Antibody Therapy and Vaccinations against COVID-19.
    Ma X; Liang J; Zhu G; Bhoria P; Shoara AA; MacKeigan DT; Khoury CJ; Slavkovic S; Lin L; Karakas D; Chen Z; Prifti V; Liu Z; Shen C; Li Y; Zhang C; Dou J; Rousseau Z; Zhang J; Ni T; Lei X; Chen P; Wu X; Shaykhalishahi H; Mubareka S; Connelly KA; Zhang H; Rotstein O; Ni H
    Research (Wash D C); 2023; 6():0124. PubMed ID: 37223472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-silico guided design, screening, and molecular dynamic simulation studies for the identification of potential SARS-CoV-2 main protease inhibitors for the targeted treatment of COVID-19.
    Gutti G; He Y; Coldren WH; Lalisse RF; Border SE; Hadad CM; McElroy CA; Ekici ÖD
    J Biomol Struct Dyn; 2024; 42(4):1733-1750. PubMed ID: 37114441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-binding domain of SARS-CoV-2 is a functional αv-integrin agonist.
    Norris EG; Pan XS; Hocking DC
    J Biol Chem; 2023 Mar; 299(3):102922. PubMed ID: 36669646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection.
    Beddingfield BJ; Iwanaga N; Chapagain PP; Zheng W; Roy CJ; Hu TY; Kolls JK; Bix GJ
    JACC Basic Transl Sci; 2021 Jan; 6(1):1-8. PubMed ID: 33102950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.